Skip to main content

Table 1 Demographics and disease characteristics of the patients included in the trial

From: High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08

CharacteristicOverall (N = 300)
N(%)
Median age (years), median (range)61(36–75)
Sex
 Male263(88%)
 Female37(12%)
Histologic Type
 Adenocarcinoma189(63%)
 Squamous cell carcinoma111(37%)
Localization (main tumour load)
 Upper part (5 cm from thoracic inlet to tracheal bifurcation)14(5%)
 Lower part (tracheal bifurcation to oesophagogastric junction)141(47%)
 Oesophagogastric junction145(48%)
Siewert Type
 Type I88(29%)
 Type II57(19%)
Clinical T stage
 uT244(15%)
 uT3246(82%)
 uT4a10(3%)
Clinical N stage
 N031(10%)
 N+269(90%)
WHO Performance Status
 0189(63%)
 1109(36%)
 Missing2(1%)